The Art of Medical Device Reimbursement: Interview with Randel Richner, Founder of Neocure Group

episode

Previously titled “The Art of Medical Device Reimbursement” — renamed by the publisher on Aug 3, 2026

Scott Nelson Live not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Scott Nelson Live

The Hidden Drivers of Clinical Trial Success: Interview with Rivermark CEO Dr. Adam Kadlec 57 min · 16 Dec 2025

Building the Market Before the Product: Interview with Inmedix CEO Andrew Holman, MD 52 min · 10 Dec 2025

All episodes from Scott Nelson Live →

Report any issue

Source

Recorded17 Nov 2020

Publisherfeeds.transistor.fm ↗

Handlerec:13866371

Show notes

This interview is a continuation of a throwback mini-series I’ve been releasing over the past few weeks with some of my favorite Medsider guests.On this particular episode, I chatted with Randel Richner, a true expert in healthcare economics and reimbursement. At the time of this interview, she was with Neocure Group, a company she founded and later sold to Intralign. Although this discussion is several years old and the audio quality isn’t ideal, Randel's insights are timeless. Here are some of the things we covered:A case study of how Randel helped save a medical device company from severe reimbursement implications.Randel’s unique “orchestra score” philosophy and how it aids in streamlining reimbursement strategies.The importance of defining the difference between how hospitals get paid and how physicians get paid.And what Randel means by the statement “comparative effectiveness is a code word for cost-effectiveness”.See more...

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.